Grameen Pharma LLP
About Grameen Pharma LLP
Data last updated:
Grameen Pharma LLP is a limited liability partnership (LLP) based in Mumbai, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 17 April 2012 and has been in existence for over 14 years.
The LLP is registered with the Registrar of Companies (ROC), Mumbai, under LLPIN AAA-8813. Its GSTIN is 27AANFG2653G1ZA (Maharashtra).
The LLP has a total obligation of contribution of ₹1 Lakh. It is led by designated partners Keval Dhirendra Shah and Dhirendra Rajnikant Shah.
Its latest statement of accounts is for the year ended 31 March 2025. The registered office is at Office Nos. 904 – 905 Prasad Chambers Opera House Girgaum Tata Road No.2, Mumbai, Maharashtra, India – 400004.
As per the financials filed for FY 2024, the LLP reported a revenue of ₹7.59 Cr, a growth of 24% compared to the previous year. For the same year it recorded a net profit of ₹1.04 Cr (net margin 13.6%) and EBITDA of ₹1.84 Cr (EBITDA margin 24.3%). Revenue has declined at a compounded annual rate (CAGR) of 15% over three years and 6% over five years.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressOffice Nos. 904 – 905 Prasad Chambers Opera House Girgaum Tata Road No.2, Mumbai, Maharashtra, India – 400004
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Financials of Grameen Pharma LLP FY 2025 filings available
Grameen Pharma LLP reported revenue of ₹7.59 Cr (up 24% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Grameen Pharma LLP
Revenue rose 24% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 6%. EBITDA rose 46% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Grameen Pharma LLP
| Statement of Account and Solvency | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Income and Expenditure | |||||
| Turnover | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Income | ₹7.59 Cr | •••• | •••• | •••• | •••• |
| Purchases and Direct Costs | •••• | •••• | •••• | •••• | •••• |
| Personnel Expenses | •••• | •••• | •••• | •••• | •••• |
| Administrative Expenses | •••• | •••• | •••• | •••• | •••• |
| Interest | •••• | •••• | •••• | •••• | •••• |
| Depreciation | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax | •••• | •••• | •••• | •••• | •••• |
| Profit After Tax | ₹1.04 Cr | •••• | •••• | •••• | •••• |
| Profit Transferred to Partners | •••• | •••• | •••• | •••• | •••• |
| Assets and Liabilities | |||||
| Partners' Contribution | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Secured Loans | •••• | •••• | •••• | •••• | •••• |
| Unsecured Loans | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Other Liabilities and Provisions | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Loans and Advances | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Grameen Pharma LLP
| Statement of Account and Solvency | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| Net Profit Margin | 13.6% | •••• | •••• | •••• | •••• |
| Return on Partners' Funds | •••• | •••• | •••• | •••• | •••• |
| Return on Assets | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt to Partners' Funds | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Turnover Growth | •••• | •••• | •••• | •••• | •••• |
| Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form 8. The full year-wise statements and ratios of Grameen Pharma are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Designated Partners of Grameen Pharma LLP
Grameen Pharma has 2 designated partners on record. No former designated partners are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Keval Dhirendra Shah Also directs: Kamalaa LLP | Designated Partner | 17 Apr 2012 | 14 Years 5 Months | Current |
| Dhirendra Rajnikant Shah Also directs: Kamalaa LLP, Sahib Singh Agencies (Bombay) Private Limited, Peak Agencies Pvt Ltd and 1 more | Designated Partner | 17 Apr 2012 | 14 Years 5 Months | Current |
Ownership and Shareholding of Grameen Pharma LLP
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Grameen Pharma LLP
Grameen Pharma LLP does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Grameen Pharma LLP
Employment history and EPFO contributions of people linked to Grameen Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Grameen Pharma LLP
Grameen Pharma LLP has 2 designated partner changes on record since 2012: 2 appointments. The latest: Dhirendra Rajnikant Shah was appointed as Designated Partner on 17 Apr 2012.
Credit Ratings, Litigation & Regulatory Alerts for Grameen Pharma LLP
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Grameen Pharma LLP
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Grameen Pharma LLP
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Grameen Pharma LLP
Grameen Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AANFG2653G1ZA | Maharashtra | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Grameen Pharma LLP
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Grameen Pharma LLP
Grameen Pharma is an active limited liability partnership based in Mumbai, Maharashtra, India. The LLP works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 17 April 2012 (14+ years old) and is registered under LLPIN AAA-8813.
Grameen Pharma reported revenue of ₹7.59 Cr for FY 2024 (up 24% YoY).
Grameen Pharma has 2 current designated partners:
- Keval Dhirendra Shah - Designated Partner
- Dhirendra Rajnikant Shah - Designated Partner
Grameen Pharma reported a net profit of ₹1.04 Cr (net margin 13.6%) and EBITDA of ₹1.84 Cr (EBITDA margin 24.3%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Grameen Pharma is 15% over three years and -6% over five years. In the latest year (FY 2024) revenue rose 24%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Grameen Pharma is 27AANFG2653G1ZA, registered in Maharashtra.
The LLPIN (Limited Liability Partnership Identification Number) of Grameen Pharma is AAA-8813. It is issued by the Ministry of Corporate Affairs and uniquely identifies the LLP in India.
Grameen Pharma was incorporated on 17 April 2012, making it 14+ years old. It is registered with the Registrar of Companies, Mumbai.
Dhirendra Rajnikant Shah was appointed as Designated Partner on 17 Apr 2012. Keval Dhirendra Shah was appointed as Designated Partner on 17 Apr 2012.
The registered office of Grameen Pharma is at Office Nos. 904 – 905 Prasad Chambers Opera House Girgaum Tata Road No.2, Mumbai, Maharashtra, India – 400004.